Entero Healthcare Solutions Ltd. (ENTERO) fundamentals
Entero Healthcare Solutions Ltd. is a listed company in Retailing, part of the Consumer Services sector, listed on the NSE as ENTERO (ISIN INE010601016). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Entero Healthcare Solutions Ltd. does
Entero Healthcare Solutions Limited is an India-based technology-driven and integrated healthcare products distribution company. It offers a range of pharmaceuticals and other healthcare products to approximately 86,200 retail pharmacies and healthcare practitioners (HCPs) across 492 districts in India. Its portfolio includes over 68,900 SKUs from more than 2000 pharma companies. The Company is a supplier to over 3,500 hospitals across India, including corporate hospital chains. It has over a network of 104 warehouses. Its technology solutions include Entero Direct, Entero CRM, Entero ERP, and Teqtic. Its Entero Direct platform is a cloud-based software-as-a-service solution that allows retailers to order their procurement needs. The Entero CRM application is a customer relationship management tool that manages and analyzes its interactions with customers, in order to customer retention and wallet share. It also offers its products through the Aayu Chemist app and Medcords platform.
Valuation and market data
| Last close | ₹1811.00 |
|---|---|
| Market capitalisation | ₹9,989 crore |
| Enterprise value | ₹10,103 crore |
| P/E (TTM) | 68.49 |
| Price to book | 5.70 |
| Price to sales (TTM) | 0.84 |
| Book value per share | ₹317.73 |
| Dividend yield | 0.00% |
| Sector | Consumer Services |
| Industry | Retailing |
| Listed since | Fri Feb 16 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹462 crore | ₹30 crore | ₹27 crore | 6.18 |
| Mar 2025 | ₹523 crore | ₹27 crore | ₹19 crore | 4.41 |
| Mar 2024 | ₹408 crore | ₹24 crore | ₹38 crore | 10.63 |
| Mar 2023 | ₹230 crore | ₹-12 crore | ₹-12 crore | -0.19 |
| Mar 2022 | ₹164 crore | ₹-41 crore | ₹-41 crore | -0.72 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 52.4% |
|---|---|
| Foreign institutions (FII) | 4.4% |
| Mutual funds | 9.0% |
| Other domestic institutions | 6.5% |
| Retail and others | 27.8% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.